BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22198488)

  • 41. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
    Burnevich EZ; Ignatova TM
    Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
    [No Abstract]   [Full Text] [Related]  

  • 42. [An immunocompromised man with a fever].
    Stapel SN; Zweegman S
    Ned Tijdschr Geneeskd; 2011; 155(18):A1700. PubMed ID: 21429253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcinosis in juvenile dermatomyositis.
    Tugnet N; Rees DH
    Postgrad Med J; 2010 Aug; 86(1018):510. PubMed ID: 20709775
    [No Abstract]   [Full Text] [Related]  

  • 45. Septic pelvic thrombophlebitis due to Staphylococcus aureus.
    Mostafavifar AM; Guilfoose J; Sarwari AR
    W V Med J; 2009; 105(3):20-2. PubMed ID: 19456034
    [No Abstract]   [Full Text] [Related]  

  • 46. [Methicillin resistant staphylococci].
    Afanas'eva TI
    Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
    [No Abstract]   [Full Text] [Related]  

  • 47. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Backache with fever and shivering. Dangerous epidural abscess].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Mar; 151(11):21. PubMed ID: 19469199
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful treatment of dermatomyositis and associated calcinosis with adalimumab.
    Xie F; Williams P; Batchelor R; Downs A; Haigh R
    Clin Exp Dermatol; 2020 Oct; 45(7):945-949. PubMed ID: 33448458
    [No Abstract]   [Full Text] [Related]  

  • 51. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C; Mahajan PV
    Pediatr Emerg Care; 2006 May; 22(5):361-3. PubMed ID: 16714967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates.
    Huang WC; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2010 Dec; 43(6):470-7. PubMed ID: 21195973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aggressive universal calcinosis complicating dermatomyositis].
    Bayou F; Belajouza C; Boussofara L; Ghariani N; Denguezli M; Bouajina E; Nouira R
    Ann Dermatol Venereol; 2011 Nov; 138(11):758-60. PubMed ID: 22078039
    [No Abstract]   [Full Text] [Related]  

  • 54. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methicillin-resistant Staphylococcus aureus toxic shock syndrome.
    Jamart S; Denis O; Deplano A; Tragas G; Vandergheynst A; De Bels D; Devriendt J
    Emerg Infect Dis; 2005 Apr; 11(4):636-7. PubMed ID: 15834985
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P; Marchandin H; Macia JC; Jonquet O
    Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lacy reticular-pattern calcinosis in adult dermatomyositis.
    Flower CH; Maynard AA
    J Rheumatol; 2013 Aug; 40(8):1406. PubMed ID: 23908532
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Methicillin-resistant Staphylococcus aureus (MRSA)--an interdisciplinary challenge].
    Esser S; Goos M; Dissemond J
    MMW Fortschr Med; 2004 Jan; 146(5):35-6. PubMed ID: 15035416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.